Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Receivables: 2017-2018

Historic Receivables for Arcus Biosciences (RCUS) over the last 1 years, with Dec 2018 value amounting to $183,000.

  • Arcus Biosciences' Receivables rose 266.00% to $183,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $5.8 million, marking a year-over-year change of. This contributed to the annual value of $183,000 for FY2018, which is 266.00% up from last year.
  • As of Q4 2018, Arcus Biosciences' Receivables stood at $183,000, which was down 96.41% from $5.1 million recorded in Q3 2018.
  • In the past 5 years, Arcus Biosciences' Receivables registered a high of $5.1 million during Q3 2018, and its lowest value of $50,000 during Q4 2017.
  • In the last 2 years, Arcus Biosciences' Receivables had a median value of $183,000 in 2018 and averaged $1.2 million.
  • Data for Arcus Biosciences' Receivables shows a peak YoY soared of 266.00% (in 2018) over the last 5 years.
  • Quarterly analysis of 2 years shows Arcus Biosciences' Receivables stood at $50,000 in 2017, then soared by 266.00% to $183,000 in 2018.
  • Its Receivables was $183,000 in Q4 2018, compared to $5.1 million in Q3 2018 and $393,000 in Q2 2018.